Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01927692 · ClinicalTrials.gov registry record
Therapeutic Plasma Exchange in MG
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 11
- Enrollment target
NCT01927692 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 11 participants.
The verdict
NCT01927692 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The primary objective of the study is to longitudinally profile immunoglobulin levels and autoantibody levels in subjects with myasthenia gravis (MG) who receive therapeutic plasma exchange (TPE).
Interventions
- OTHER Skin biopsy
- OTHER Single Fiber Electromyography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01927692
The ClinicalTrials.gov registry entry for NCT01927692 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Skin biopsy is the first listed.
NCT01927692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01927692 about?
NCT01927692 is a clinical study titled "Therapeutic Plasma Exchange in MG". The primary objective of the study is to longitudinally profile immunoglobulin levels and autoantibody levels in subjects with myasthenia gravis (MG) who receive therapeutic plasma exchange (TPE).
What is the current status of trial NCT01927692?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2013-07. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01927692?
The interventions under investigation include: Skin biopsy (OTHER), Single Fiber Electromyography (OTHER).
Who is sponsoring clinical trial NCT01927692?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.